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NOVEL APPROACHES TO WHITE ADIPOSE BROWNING AND BEIGE 
ADIPOSE ACTIVATION FOR THE TREATMENT OF OBESITY 
TED GOH 
ABSTRACT 
 
Brown and beige fat are specialized adipose tissues found in almost all mammals that can 
increase energy expenditure and produce heat. Cold exposure and b3-adrenergic 
stimulation has been extensively shown to activate brown adipose tissue (BAT) in 
rodents, which promotes uncoupled respiration of glucose and lipid substrates via 
uncoupling protein 1 (UCP1). Prolonged stimulation can induce white adipose browning, 
which leads to the emergence of thermogenic cells within white fat depots, called beige 
adipocytes. The beige adipocyte possesses a unique molecular signature, yet shares 
several characteristics of brown adipocytes, including high mitochondrial content. When 
activated, beige fat can be induced to initiate a thermogenic transcriptional program 
similar to that of BAT. Recent human studies have identified brown and/or beige fat in 
the supraclavicular region using various radiation imaging modalities. This remarkable 
discovery has reinvigorated scientific interest in adipose browning and brown/beige fat 
activation as possible therapeutic targets for obesity. Like in rodents, several groups have 
previously tested the potential impact of cold exposure and  b3-adrenergic agonism on 
BAT-mediated thermogenesis in humans. However, even though these approaches were 
shown to significantly increase energy expenditure and promote weight loss in obese 
individuals, they are not ideal clinical interventions. Cold exposure is uncomfortable and 
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requires prolonged treatment, while b3-adrenergic agonists may lead to many adverse 
effects like cardiovascular problems. This thesis will evaluate the therapeutic potential 
and clinical relevance of alternative anti-obesity approaches that target adipose browning 
and beige adipose activation. 
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INTRODUCTION 
 
The global prevalence of obesity and excess weight has risen significantly over 
the past three decades, from 921 million in 1980 to 2.1 billion in 2013, 1 and continues to 
rise, representing one of the greatest health challenges of the 21st century. In the United 
States, as described in the most recent 2015 National Health and Nutrition Examination 
survey2, 36.5% of adults and 17% of youth were obese in 2011-2014. Obesity is 
associated with several comorbidities, including diabetes, hypertension, heart disease, 
and dyslipidemia, which have significant economic impacts on health care.3 Beyond 
critical lifestyle interventions such as diet and exercise, anti-obesity drugs like orlistat 
(XENICAL),4 a lipase inhibitor, act to reduce caloric intake and/or manage appetite. 
However, their efficacies are modest and are associated with many adverse side effects, 
like nausea and constipation.4,5 Furthermore, there are no approved pharmacologic agents 
shown to increase energy consumption.4 As a result, novel therapeutic approaches are 
required to counter the rising prevalence of obesity worldwide.  
Obesity is caused by a chronic increase in energy intake (from food) relative to 
energy expenditure (EE), leading to excess fat storage, lipid deposition in other tissues, 
and weight gain.5 Much of this energy is stored as triacylglycerol in white adipose tissue 
(WAT), which can be released during energy demand. However, the mammalian adipose 
organ also contains cells that burn substrates like fatty acids and glucose to produce heat 
in response to various stimuli: brown and beige (or ‘brown-in-white’/‘brite’/‘inducible 
brown’) adipocytes (Figure 1).6-11 Recently, brown adipose tissue (BAT) activation and 
beige adipocyte induction in WAT depots have sparked considerable interest as anti-
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obesity strategies that act by dissipating energy via thermogenesis. Sufficient 
brown/beige adipose activation can burn excess food-derived nutrients to limit lipid 
accumulation in WAT, facilitate weight loss, and improve metabolic health.  
 
 In rodents, classical BAT has been well characterized as a highly vascularized, 
mitochondria-rich tissue containing numerous lipid droplets (multilocular) evolved for 
energy production in the form of heat during periods of low temperature.6-9 In contrast, 
white adipocytes store energy, having unilocular lipid droplets and few mitochondria.6 
Classic brown adipocytes derive from a myogenic (Myf5+) myogenic lineage, instead of 
Figure 1 – Beige adipocyte morphology in human visceral adipose tissue. Left: Light 
microscopy slide reveals presence of multilocular adipocytes among unilocular white 
adipocytes. Right: Electron microscopy of area indicated in the left. High 
mitochondrial content in the beige adipocyte contrasts with poor content localized at 
the cytoplasmic rim of white adipocytes. Figure adapted from Cereijo et al. (2015).11  
	 	 	
  3 
Figure 2 – Schematic of adaptive thermogenesis in brown/beige adipocytes. Earlier 
studies have shown that these cells can be activated indirectly by cold via the 
sympathetic nervous system (SNS). Catecholamines (i.e. norepinephrine (NE)) 
bind the b-adrenergic receptor (b-AR) to activate UCP1-dependent thermogenesis. 
However, a futile creatine cycling mechanism for heat production has also been 
reported. Other stimuli are continually discovered via other pathways, some of 
which are discussed in this thesis. Briefly, reducing equivalents from the 
tricarboxylic acid (TCA) cycle enter the electron transport chain (ETC), which 
generates to proton gradient across the inner mitochondrial membrane. Normally, 
this gradient is linked to ATP synthesis through Complex V (ATP Synthase), but 
UCP1 uncouples the gradient to convert chemical energy to heat. Figure adapted 
and amended from Cohen & Spiegelman (2015).13   
from that of white adipocyte precursors.12 When brown adipocytes are stimulated by cold 
exposure, b-adrenergic agonism, or other factors, they initiate a thermogenic 
transcriptional response critically mediated by uncoupling protein 1 (UCP1).6-7 When 
BAT is activated, UCP1 acts to uncouple electron transport from adenosine triphosphate 
(ATP) production at the inner mitochondrial membrane (Figure 2).7-8 Increased glucose 
and free fatty acid (FFA) utilization results in high levels of uncoupled respiration to 
produce heat.   
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            Beige adipocytes have been recently identified as another type of thermogenic 
cell, which phenotypically appear as white adipocytes possessing “brown-like” 
characteristics like multilocular lipid droplets and high mitochondrial content.7-12 
Interestingly, they develop in a lineage separate from that of brown and white adipocytes 
(Myf5-), providing evidence that they are generated de novo.14 They reside in clusters 
within WAT depots and tend to express little/no levels of UCP1 in the basal state, but 
when stimulated (e.g. by cold exposure), can dramatically ramp UCP1 mRNA and 
protein expression to that of activated BAT to initiate nonshivering thermogenesis.8-11 
When the applied stimulus is removed, beige adipocytes may revert to a “white-like” 
phenotype, demonstrating a remarkable plasticity.9  
          Numerous studies confirm that cold exposure and adrenergic signaling can not only 
recruit and activate preexisting BAT in mice, but also induce beige adipocyte 
differentiation from adipose precursors within WAT depots11 or alternatively, by 
transdifferentiation of mature white adipocytes.15-17 Both developmental processes are 
independent from each other and may co-exist in vivo, but evidence supporting 
transdifferentiation for beige adipogenesis is still hotly debated. The process describing 
the emergence of beige adipocytes in WAT due to thermogenic demand or applied 
stimuli is widely termed as adipose “browning”.18  
Radiological and molecular analyses have undisputedly confirmed the existence 
of thermogenic adipocytes with “BAT-like” signatures mainly within the supraclavicular 
neck region of humans (Figure 3).19-20 Early studies utilized 18F-fluoro-2-deoxy-D-
glucose (FDG)-positron emission tomography computed tomography scans (referred to 
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herein as FDG-PET/CT) to measure glucose uptake in human BAT, which served to 
estimate BAT mass.19-21  
 
 
 
 
 
 
 
 
18F-FDG uptake in supraclavicular adipose tissue significantly increased in  
approximately 40-50% of normal-BMI subjects when exposed to mild cold,19-21 but the 
total tissue mass appeared quite low relative to body weight.19 Later studies showed that 
BAT mass inversely correlated with BMI, adiposity, and age.22 Due to the relatively low 
Figure 3 – Anatomical locations of BAT in humans and mice. (A) In rodents, 
interscapular and perirenal BAT are composed of classical brown adipocytes. Beige 
adipocytes are mainly found in subcutaneous WAT (inguinal and epididymal, but 
mostly inguinal). (B) Adult human BAT is found mostly in the supraclavicular region, 
but also in cervical and paravertebral regions. In infants, BAT is more prominent 
relative to body mass, found in the interscapular and perirenal regions analogous to 
rodents. Figure adapted from Siddosis & Kajimura (2015).7  
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quantity of pre-existing human BAT in obese individuals, it seems unlikely that sole BAT 
activation would yield clinically significant contributions to whole-body EE.8-11  
Recent gains in our understanding of beige adipocyte development raise the likely 
possibility that this BAT-like tissue might be partially or completely composed of beige 
adipocytes. Many beige-specific marker genes including TBX1, CD137, TMEM26, and 
CITED1 have been identified, and continue to be identified, for molecular 
characterization (Table 1).23-24 Human UCP1-positive adipocytes isolated from the 
supraclavicular region had high levels of ‘beige’ gene expression, while lacking 
expression of genes specific to classic brown adipocytes.24  
 
 
 
 
Table 1 – Confirmed marker genes for various adipocyte classes in humans. References 
(rightmost column) can be retrieved from Cereijo et al. (2015).11  
	 	 	
  7 
Cypress et al.25 identified cells resembling classical murine brown adipocytes in 
the deep fat layers of the neck via morphological characterization, UCP1 expression 
quantification, and surface marker analysis. Meanwhile, FDG-PET/CT-positive adipocyte 
clusters in the larger, outer fat layers displayed a beige phenotype. These results were 
supported by separate studies of brown/beige adipocytes isolated from adult neck 
biopsies, which verify that supraclavicular BAT may simultaneously consist of both 
brown and beige adipocytes.19-21,26 Gene signatures of thermogenic adipocytes vary 
depending on neck depth, suggesting a complex heterogeneity.24 However, there is still 
no consensus on the relative proportions of brown and beige adipocyte populations, and if 
they differ with anatomical location and age. But what is certain, is that adipose depots 
express UCP1, can increase uptake of circulating energy substrates, and have 
thermogenic capacity.27 For simplicity’s sake, this heterogeneous thermogenic tissue will 
collectively be referred to here as “human BAT.” Additional studies are needed to more 
confidently distinguish the functional and genetic differences of both cell types.  
The “recruitable” nature of beige adipocytes makes WAT browning an attractive 
target process for obesity and its comorbidities. In theory, beige adipocytes can be 
differentiated and activated by various external and internal cues to dissipate food-
derived energy substrates. b3-adrenergic agonists (e.g. CL 316,243 compound) have been 
extensively shown to activate brown/beige fat in rodents and are commonly used for 
experimentation.7-8 However, their efficacy in human clinical trials have been largely 
disappointing due to limited oral bioavailability and risk of adverse effects, including 
hyperthermia, tachycardia, and elevated blood pressure.4 Perhaps the most successful 
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example is mirabegron (MYRBETRIQ), an approved b3-agonist used to treat overactive 
bladder, which has recently been shown to activate human BAT and increase resting 
energy expenditure (REE) by ~13%.28-29 Nonetheless, few other pharmacologic 
compounds have shown such translatable potential. Hence, it is critical to obtain a more 
comprehensive understanding of beige adipocyte biology and mechanisms of browning to 
develop feasible methods for beige cell recruitment and activation in obese individuals. 
This thesis aims to evaluate the therapeutic potential and clinical relevance of 
recent anti-obesity therapeutic approaches that target human adipose browning and beige 
adipose activation. Firstly, chronic cold exposure is an approach that works impressively 
well in both rodents and humans to increase energy expenditure and thermogenesis, but 
its practicality as prescribed clinical therapy will be assessed. Healthy diet, exercise, and 
bariatric surgery are well-known lifestyle modifications individuals may employ to 
reduce or prevent adiposity; however, recent studies suggest that these interventions may 
also promote WAT browning through non-adrenergic, independent pathways. 
Additionally, with the discovery of numerous microRNAs crucial for brown/beige 
adipocyte development, microRNA therapeutics may represent a novel, pharmacological 
avenue to combat obesity. Lastly, the complex possibility of beige adipose 
transplantation using differentiated human adipogenic stem cells will be explored.  
 
 
 
 
	 	 	
  9 
CHRONIC COLD EXPOSURE 
 
Reduction of temperature is one of the more established environmental factors 
found to both initiate BAT thermogenesis and induce beige adipogenesis from adipocyte 
precursors.30-32 Briefly, chronic cold exposure stimulates the release of catecholamines 
(i.e. norepinephrine (NE)) at sympathetic terminals of WAT and the adrenal medulla, 
which binds to the b3-adrenergic receptor (b3-AR). b-adrenergic signaling activates the 
protein kinase A (PKA) and p38 mitogen-activated protein kinase (p-38 MAPK) 
pathways, followed by phosphorylation of several adipogenic factors, including 
peroxisome proliferator-activated gamma coactivator 1 alpha (PGC1a), cAMP response 
element-binding protein (CREB), and activating transcription factor 2 (ATF2). This 
complex, yet well-orchestrated transcriptional program equips the target cell with 
thermogenic machinery that (i) generates intracellular FFA through lipolysis, (ii) 
promotes glucose intake, and (iii) upregulates/activates UCP1 (Figure 4).33 Chronic cold 
challenge induces WAT browning through even more complex cellular processes 
involved in cell proliferation, mitochondrial biogenesis, and angiogenesis.32   
Alternatively activated (M2) macrophages in subcutaneous adipose tissue also 
gain the capacity to produce catecholamines upon acute cold exposure, which may 
contribute to browning. Recent studies have determined that cold-induced macrophage 
activation is regulated by a complex immunogenic circuit.34-36 Type 2 innate lymphoid 
cells (ILC2s) are T helper lymphocytes that produce IL-4, IL-5 and IL-13. A reduction of 
this cell type in adipose tissues is associated with obesity in mouse and humans.37  
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During cold exposure, ILC2s are triggered by IL-33 to produce IL-5, which in turn 
stimulates eosinophil IL-4 secretion. IL-4 binds to IL-4 receptors present on both adipose 
macrophages and adipocyte precursors, which has two main functions: stimulation of 
macrophage-derived NE secretion and commitment of adipocyte precursors to brown or 
beige differentiation. 
 
Figure 4 – Schematic describing the effects of cold on activating brown/beige 
adipocytes. Norepinephrine (NE) is secreted directly from the sympathetic nervous 
system (SNS) or by type 2 macrophages (not pictured). NE binding to the b-AR 
activates a thermogenic transcriptional program to increase glucose and free fatty acid 
(FFA) uptake, mitochondrial biogenesis, and UCP1 expression. Figure adapted from 
Peng et al. (2016).33 
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Several clinical studies in human adults have demonstrated that cold exposure 
activates BAT and promotes WAT browning. Yoneshiro et al.38 treated 51 healthy young 
males with acute, 2-hour cold exposure (17 °C), administered via a temperature-
regulating cooling vest in a cold room. Approximately half of subjects showed cold-
activated BAT (BAT-positive), assessed via higher FDG-uptake into supraclavicular 
depots using FDG-PET/CT (Figure 5). While whole-body EE measured by respiratory 
gas analyzer showed no difference between BAT-positive and BAT-negative groups in 
warm (27 °C) conditions, the EE difference between groups increased by 3-fold in cold. 
FDG uptake was negligible in other tissues, like skeletal muscle, which ruled out 
significant contribution of shivering thermogenesis towards EE.  
 
 Figure 5 – FDG-PET/CT scans. (A) Examples of BAT-positive (left) and BAT-negative 
(right) scans following cold exposure, as categorized by Yoneshiro et al. (2013). Most FDG-
uptake occurs in interscapular BAT. (B) Whole-body FDG-PET images under cold or warm 
conditions; Saito et al. (2009. Left: 25 year old male subject kept in air-conditioned room 
(19 °C) with light clothing, with legs put on ice block intermittently (~ 4 min at every 5 
min.). He was treated for 1 hour, then given 18F-FDG and resumed treatment for another 
hour. Afterwards, FDG-PET/CT was performed at 24 °C. Right: The same individual was 
kept at 27 °C with standard clothing (warm condition) for 2 hours before FDG-PET/CT 
analysis. Figures adapted and amended from Yoneshiro et al. (2015)38 in (A), and Saito et al. 
(2009)40 in (B). 
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Secondly, Yoneshiro et al. also examined the effect of chronic cold exposure on 
subjects with undetectable BAT (i.e. BAT-negative). Out of 8 BAT-negative subjects that 
underwent daily 2-hour cold exposure (17 °C) for 6 weeks, 6 out of 8 showed active BAT 
by week 6. Additionally, these subjects exhibited a 2-fold increase in EE during cold and 
reduction in body fat mass compared to BAT-negative controls (i.e. normal lifestyle 
without cold exposure). Altogether, these results suggested for the first time that chronic 
cold can induce WAT browning and increase UCP1 expression in pre-existing human 
BAT to increase whole-body EE and reduce body fat.  
Chondronikola et al.39 performed a more in-depth follow-up by testing other 
metabolic parameters with 2.5x longer acute cold exposure conditions. Prolonged daily 
cold exposure for 5-8 hours increased REE by ~15%, due to plasma glucose utilization 
(30%) and FFA oxidation (70%) in BAT-positive individuals. In another part of their 
study, a hyperinsulinemic-euglycemic clamp was used to assess insulin-stimulated 
glucose disposal, mimicking a postprandial (fed) state. Insulin infusion in thermoneutral 
conditions increased whole-body glucose disposal in both BAT-positive and BAT-
negative groups to a similar extent. However, insulin infusion at the end of a mild 5-hour 
cold exposure led to a higher glucose disposal in BAT-positive subjects compared to the 
amount observed at thermoneutrality. No difference was observed in the BAT-negative 
group after cold exposure. Using empirical analysis of these results, Chondronikola et al. 
predicted that continuously active human BAT (~ 70 ml) could dispose ~23 g of plasma 
glucose in 24 hours, suggesting that BAT may also have a significant role in glycemic 
control and diabetes management.   
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Although cold exposure is sufficient to activate human BAT and recruit beige 
adipocytes, it may be a logistically difficult therapy to implement for a number of 
reasons. Considering the experimental conditions stated in the studies above, cold 
temperatures would have to be endured for hours at a time, over a period of several 
weeks or months, to see significant results. Access to ambient cooling systems and body 
cooling equipment may be expensive and impractical, especially for those living in 
warmer climates. Additionally, due the plasticity of beige adipocyte recruitment, human 
BAT loses thermogenic capacity within a few hours following the removal of cold 
stimulation38-41 – prolonged activation may be achieved through co-treatment of other 
pharmacological interventions. Lastly, genetic variations among individuals may affect 
the basal quantity of BAT and its capacity for cold-activation. Many studies have 
reported that cold-activated BAT was detected in approximately 50% of young adults via 
FDG-PET,42-43 in agreement with the results discussed above. Also, as discussed, this 
proportion is likely to decrease in obese individuals, as BAT mass inversely correlated 
with age and BMI.42  
At this time, it is unclear whether (i) chronic cold stimulation causes beige 
adipocytes to “deactivate” or downregulate expression of thermogenic molecular 
machinery and (ii) there is a latency for beige differentiation if too long a delay is 
established before reinstating the next cold treatment. Considering these complex 
concerns, alternative therapeutic strategies for WAT browning and beige activation still 
need to be developed.  
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LIFESTYLE MODIFICATIONS 
 
As previously discussed, cold exposure or b3-AR activation may not be suitable 
therapeutic options in humans. Cold treatment is uncomfortable and b3-AR activation has 
been shown to cause sweating and increase the risk of cardiovascular disease. Dietary 
factors, exercise, and bariatric surgery are health interventions that have numerous 
metabolic benefits, one of which includes adipose browning.  
 
Dietary factors 
Several bioactive ingredients found in common herbs, plants, and over-the-
counter dietary supplements have been reported to have anti-obesity and thermogenic 
properties. These include certain phytochemicals like green tea epigallocatechin gallate 
(EGCG), fish oil, and vitamin A conjugates (Figure 6).44 However, few dietary molecules 
have demonstrated potential for WAT browning and adaptive thermogenesis in vivo. 
Here, the plant-based compounds capsinoid, curcumin, and cinnamon are given special 
consideration.  
Capsinoids are found in a wide variety of peppers and include the pungent analog 
capsaicin in chili peppers. They mainly act to increase EE and enhance thermogenesis by 
stimulating transient receptor potential (TRP) channels (e.g. TRPV1 and TRPA1) found 
in the gut, which ultimately activates sympathetic efferent nerves to brown and white 
adipose tissues.45 The precise mechanism by which capsinoids influence the sympathetic 
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nervous system is not fully understood, but it is likely that TRP binding activates the 
afferent gastrointestinal vagus nerve and/or directly stimulates catecholamine secretion.46  
 
 
Yoneshiro et al.47 orally administered capsinoids (9 mg) to 18 healthy men 
followed by 2 hr. of cold treatment (19 °C), and measured whole-body EE using FDG-
PET/CT. As expected, cold exposure increased adipose FDG-uptake in both BAT-
positive and BAT-negative groups, but a greater increase was observed for the BAT-
positive group. However, capsinoid ingestion concurrent with cold exposure resulted in a 
Figure 6 – Thermogenic dietary molecules and their potential mechanisms of 
action. Dietary factors can lead to 3 distinct metabolic responses: (i) Increase BAT 
activity; (ii) WAT browning; (iii) transdifferentiation of mature white adipocytes to 
beige adipocytes in subcutaneous tissue. Many of these molecules have 
overlapping signaling pathways. Figure taken from Okla et al. (2017).44 
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3-fold increase in EE in the BAT-positive group compared to the BAT-negative group. 
Chronic ingestion (9 mg/day) for 6 weeks led to greater BAT activity and decreased fat 
mass upon cold exposure, even in the BAT-negative group.   
In line with this study, Nirengi et al.48 evaluated supraclavicular BAT density in 
20 subjects taking daily 6-week capsinoid treatment. Both FDG-PET/CT and near-
infrared time-resolved spectroscopy techniques confirmed a ~50% increase in BAT 
activity at the end of the study period. Interestingly, 8-weeks after the treatment period, a 
12.5% decrease in activity was observed. Thus, similar to what was seen in the chronic 
cold exposure case, the removal of capsinoid administration leads to gradual 
‘deactivation’ or ‘reversal’ of human BAT activity and/or beige adipogenesis back to a 
basal state.   
Lastly, Ohyama et al.49 performed an in-depth mechanistic study in C57BL/6J 
mice and found that a combination of mild 17 °C cold exposure and capsinoid treatment 
(0.3%) synergistically and preferentially promoted inguinal WAT browning and 
ameliorated diet-induced obesity. Capsinoid action enhanced the half-life of PRDM16, an 
important transcription factor for brown/beige adipocyte development, and appeared to 
function through the b2-AR signaling pathway Altogether, further studies are needed to 
determine the direct effect of capisinoids on human BAT and browning and whether 
pharmacologic doses (10 mg/day) are sufficient for BAT activation and beige adipocyte 
recruitment.   
Curcumin is a yellow bioactive of turmeric and used as a medicinal herb for anti-
obesity effects.50 Di Pierro et al.51 performed a randomized controlled study evaluating 
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the efficacy of 30 day curcumin (complexed with phosphatidylserine) consumption in 44 
obese patients who previously showed < 2% weight loss after 30 days of lifestyle 
interventions (e.g. nutrition education, diet, and exercise). Curcumin administration 
increased weight loss from 1.9 to 4.9%, body fat from 0.7 to 8.4%, and BMI from 2.1 to 
6.43% (p <0.01 for all comparisons).  
Although no evidence of curcumin-mediated browning has been demonstrated in 
humans, a few studies have shown beige phenotype induction ex vivo in rodent primary 
white adipocytes, assessed by beige-specific marker induction (e.g. Cidea, Pgc1a, and 
Prdm16).52-53 Wang et al.54 showed that curcumin (50 or 100 mg/kg) administered 
intragastrically in mice over 50 days increased thermogenic gene expression and 
mitochondrial biogenesis in inguinal WAT. These mice exhibited decreased body weight 
(without changes in food intake) and improved cold tolerance. Curcumin increased b3-
AR expression and plasma NE levels, which may have mediated the browning effect; 
however, the precise mechanism of its action is unclear.  
Lastly, cinnamon is a common spice shown to improve insulin sensitivity and 
exert other beneficial metabolic effects,55 yet its anti-obesity effects are less studied. 
Gupta-Jain et al.56 performed a randomized double-blind trial to evaluate the effect of 
oral cinnamon consumption (3 g/day for 16 weeks) on Asian Indians with metabolic 
syndrome. The cinnamon group exhibited significantly decreased fasting blood glucose, 
BMI, and waist circumference than placebo. Mechanistically, cinnamaldehyde, the 
chemical that imparts cinnamon’s flavor, has been shown to activate TRPA1 to limit 
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ghrelin secretion and gastric emptying in mice, which altogether functions to suppress 
appetite.57 
Kwan et al.58 showed that cinnamon extract (CE; 80 µg/ml) induced browning in 
3T3-L1 adipocytes and murine primary subcutaneous adipocytes. In both models, CE 
promoted a multilocular phenotype, increased mitochondrial biogenesis, and upregulated 
Ucp1 and other beige marker gene expression. Additionally, in vivo, oral administration 
to diet-induced obesity mice (DIO; high fat diet for 5 weeks) reduced body weight and 
increased UCP1 expression in subsequently isolated adipocytes from subcutaneous fat 
pads.  Closer examination revealed that CE directly or indirectly activates the b3-AR, as 
adipocytes co-incubated with CE and b-AR antagonist SR59230A failed to yield 
evidence of browning. As cinnamon extract contains many bioactives including 
cinnamaldehyde, cinnamate, and other polyphenols, it would be interesting to identify 
that exact compound(s) that mediate cinnamon’s browning effects.  
In summary, numerous dietary factors like capsinoids, curcumin, and cinnamon 
could be included in dietary regimens to manage or prevent obesity via BAT-mediated 
thermogenesis. Interestingly, the aforementioned compounds are all linked to the b3-
adrenergic pathway, acting either by direct or indirect b3-AR activation or catecholamine 
secretion. Chronic ingestion of high doses (>10 mg) of capsinoids appear effective in 
humans, but the safety of longer-term use needs further evaluation. Polyphenols like 
curcumin have been shown to activate beige/brown fat in rodents, but they have poor 
availability in humans and require high doses (~100 mg/kg) for thermogenic activation, 
which would be supraphysiological for human trials. Collectively, there is emerging 
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evidence that dietary molecules have a role in brown/beige fat activation, but direct data 
supporting diet-induced WAT browning is hitherto fragmented and their underlying 
mechanisms have yet to be clearly established.  
 
Physical exercise and irisin 
Exercise is well known to be beneficial for numerous metabolic parameters, 
including whole-body glucose homeostasis, insulin sensitivity, and adiposity reduction.59 
In WAT, exercise decreases adipocyte size and absolute lipid content in mice.60 
Additionally, it may also promote browning of subcutaneous WAT and increase EE in 
mice. 61-62 Recent data suggest that exercise-induced benefits appear to be mainly 
mediated by PGC1a in skeletal muscle.62 PGC1a is a mitochondrial factor that regulates 
oxidative phosphorylation, mitochondrial biogenesis, muscle fiber-type switching, and 
whole-body energy homeostasis.63  
PGC1a-dependent browning during exercise may be related to irisin, a myokine 
proteolytically cleaved at the C-terminus from the membrane protein fibronectin type III 
domain-containing protein 5 (FNDC5 gene) precursor.63-65 In 2012, Boström et al.63 first 
showed in mouse that muscle PGC1a stimulates the expression of FNDC5, which is 
cleaved and secreted as irisin (Figure 7). Irisin directly binds a white adipocyte surface 
receptor (unidentified) to induce beige differentiation and UCP1 expression, which 
resulted in increases in EE, modest weight loss, and improvements in glucose sensitivity.  
 
 
	 	 	
  20 
 
The physiological role of irisin as an exercise-induced browning agent in humans 
is controversial. Although many groups have observed an acute increase in irisin 
following exercise, other clinical studies have not demonstrated a positive correlation 
between exercise, irisin, and browning. In their seminal study, Boström et al.63 reported 
that 10 weeks of combined endurance and resistance training increased irisin levels in 
obese, type 2 diabetic adults by 2-fold, which was proportional to increases in FNDC5 
mRNA transcript number in skeletal muscle. More recently, Lee et al.66 observed a 3-fold 
increase in subjects after an hour of cycling at moderate intensity (40% VO2 max), but 
Figure 7 – Putative effects of FNDC5 or irisin on browning, improvements in 
energy expenditure, and metabolic health in mice and humans. Figure adapted from 
Irving et al. (2014).65  
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intriguingly, no change in irisin levels occurred after a maximal cycling intensity test, 
suggesting a dose-response effect. 
In line with this data, Moreno et al.67 measured circulating irisin levels by ELISA 
in 428 subjects and found that they were higher in active subjects (self-reported), 
particularly those in living in rural environments, than in sedentary individuals. Lastly, 
perhaps presenting the most definitive evidence of exercise-induced irisin secretion, 
Jedrychowski et al.68 quantified circulating irisin by state-of-the-art tandem mass 
spectrometry. Aerobic exercise significantly increased irisin levels from ~3.6 ng/ml in the 
sedentary state to ~4.3 ng/ml during interval training. However, the question of whether 
such an increase had any physiological impact in terms of human BAT activation or 
WAT browning was not pursued in this study.  
In contrast, other randomized clinical trials failed to detect an increase in 
circulating irisin. Hecksteden et al.69 observed no change in subjects who underwent 
endurance exercise 3 times per week for 26 weeks, while Hew-Butler et al.70 saw no 
difference in irisin levels between runners and non-runners. However, an important 
observation from these studies was that irisin underwent storage degradation over time 
upon freezing, which possibly calls into question the interpretation of other clinical 
studies lacking time-matched controls.  
Most evidence generally supports the claim that circulating irisin levels are 
increased after exercise, but conflicting results may be due to inaccurate commercial 
detection methods (e.g. antibodies and ELISAs). For example, it is not clear whether 
identified irisn by western blot is a fragment of FNDC5 or full FNDC5, since the true, 
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unglycosylated molecular weights of cleaved species are only theoretically proposed, but 
not yet accurately elucidated.63 In addition, irisin appears to be influenced by various 
phenotypic traits including adiposity, muscle mass, and fasting plasma glucose, which 
may further explain the inconsistencies in human trials.64-65  
Lastly, to add to the confusion, Roca-Rivada et al.71 showed that irisin can be 
secreted not only as a myokine, but also as an adipokine from WAT in rats. 
Unexpectedly, circulating irisin levels decreased after acute exercise. In line with this 
evidence, Pardo et al.72 found higher irisin levels and resting EE in obese individuals 
independent of acute exercise, compared to that found in anorexic or normal BMI 
subjects. This surprising result suggests a possible muscle-adipose crosstalk and/or type 
of resistance to irisin in the obese condition, as previously observed in other adipokines 
like leptin. This irisin-resistance hypothesis may partially explain the low quantity of 
BAT found in obese adults. All in all, further studies are warranted to determine the yet 
unidentified pathway of irisin action and whether this molecule acts as a factor that 
propagates or treats obesity.   
 
Bariatric surgery and bile acids 
Bariatric surgery has proven to be the most effective therapy for weight loss and 
remission of type 2 diabetes for the morbidly obese.73-76 Common procedures include 
reducing/removing portion of the stomach to reduce its size (e.g. sleeve gastrectomy) and 
resecting/re-routing the small intestine to the stomach (i.e. gastric bypass), which both 
promotes caloric restriction (Figure 8).76 How bariatric surgery produces these profound 
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metabolic improvements are still unclear. Interestingly, several groups report that gastric 
bypass increases EE in rodents and humans, which may help prevent weight gain in the 
long-term.74-75 Whether this phenomenon is due to an increase in activated BAT or 
recruited beige adipocytes after surgery has yet to be fully determined.  
Vijgen et al.78 followed 10 morbidly obese subjects 1 year before and after 
receiving laparoscopic adjustable gastric banding (LAGB) surgery to measure possible 
increases in BAT activity. Before surgery, 2 out of 10 subjects were identified as BAT-
positive, assessed via FDG-PET/CT following acute cold stimulation. One year after 
surgery, this number increased to five, all showing higher cold-induced BAT activation 
compared to before surgery. Although Vijgen et al. found that weight reduction via 
Figure 8 -  The three main bariatric surgery interventions. (A) Laparoscopic adjustable 
gastric banding. A small pouch is created in the upper part of the stomach. A silicon band is 
connected to a subcutaneous port that allows band adjustment. (B) Sleeve gastrectomy. A 
large portion of the stomach is irreversibly resected, while leaving the pyloric sphincter 
intact. (C) Roux-en-Y gastric bypass. A small gastric pouch is directed to the distal jejunum 
by the Roux limb. The distal stomach, duodenum, and proximal jejunum is then 
anastomosed below the gastrojejunal anastomosis. Figure adapted and amended from Aron-
Wisnewsky et al. (2012).76 
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LAGB may contribute to BAT activation and browning, their study’s sample size was 
small and provided few mechanistic clues. They suggested that increased presence of 
BAT after surgery could be a direct effect of decreased insulation due to significant 
subcutaneous fat loss, but definite conclusions require larger, in-depth clinical studies.  
Other mechanisms may involve changes in hormone or signaling molecule 
secretion and/or activity after bariatric surgery. One possible hormonal class includes bile 
acids (BAs), nutrient-responsive lipid hormones that have key roles in glucose, lipid, and 
energy homeostasis.79 BAs primarily respond to nutrient intake in the postprandial (fed) 
state by assisting the digestion of fats and fat-soluble vitamins, but among other 
physiological functions, have also been shown to increase EE in skeletal muscle and 
BAT.80-83  Postprandial levels of circulating BAs are strongly correlated with postprandial 
EE in lean individuals and are preferentially decreased in obesity by on average ~50%.82  
Clinical studies80,83 have largely confirmed that fasting or postprandial plasma BA 
concentrations are increased following Roux-en-Y gastric bypass (RYGB), normalizing 
the blunted BA response associated with obesity. Prior studies84-85 suggest that 
accelerated delivery of BAs to the distal ileum after RYGB may explain increases in 
circulating BAs, as it shortens the distance between the stomach to the ileum by 
bypassing the proximal intestine. However, anatomic change is an unlikely explanation, 
since these effects are evident around 2-weeks post-operation, lasting for at least 40 
weeks.  
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BAs appear to activate BAT in rodents in vivo and human primary brown 
adipocytes ex vivo by activating the TGR5 G-protein coupled receptor, which results in 
increased levels of cAMP (Figure 9).86 Elevated intracellular cAMP activates type 2 
deiodinase (D2) and helps stimulate D2 expression, which converts inactive thyroid 
hormone thyroxine (T4) to the active form triiodothyronine (T3). Active thyroid hormone 
then in turn upregulates genes involved in oxygen consumption, mitochondrial 
uncoupling, and EE.  
 
Figure 9 – Mechanism of bile acid (BA)-mediated brown fat activation. Bile acids are 
synthesized from cholesterol in the liver, stored in the gallbladder, and secreted after 
meals to promote absorption of fat from the intestine. They are then either excreted or 
reabsorbed into the circulation. BAs bind to TGR5, which increases intracellular 
cAMP and induces D2 expression, promoting the conversion of T4 to active T3 and 
increasing metabolic rate. Figure adapted from Watanabe et al. (2006).86  
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As a proof-of-concept, Broeders et al.87 found that administration of the BA 
chenodeoxycholic acid (CDCA) to 12 BAT-positive female subjects (15 mg/kg for 2 
days) resulted in activated BAT under thermoneutrality (i.e. basal, resting state), 
accompanied by a 5-6% increase in EE. Secondly, primary brown/beige and white 
adipocytes were cultured from the “BAT”-region of these subjects as they underwent 
thyroid surgery to explore the mechanism of CDCA action. CDCA was found to activate 
brown/beige adipocytes by the TGR5-D2-T3 pathway, but not in mature white 
adipocytes. Because of UCP1 induction in these cells, the absolute increase in 
mitochondrial uncoupling rose 2-fold, in comparison to the 3-fold increase observed upon 
NE treatment (positive control).  
Although Broeders et al. did not observe ‘browning’ of primary white adipocytes, 
it is probable that the cultured fraction did not contain beige precursors or BA species 
other than CDCA may be involved in browning. In line with this possibility, another 
group87 treated mice with agonists of the BA sensor farnesoid X receptor (FXR), which 
enhanced thermogenesis and WAT browning in vivo. Thus, although more prolonged 
studies are warranted, BA supplements and TGR5/FXR agonists may be therapeutic 
avenues for counteracting obesity.   
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SHORT NONCODING RNAs 
 
MicroRNAs (miRNAs) are short noncoding RNAs ~20 nucleotides in length that 
regulate gene expression mainly via sequence specific hybridization to the 3’ untranslated 
region (UTR) of target mRNAs.89 This interaction inhibits translational machinery from 
encoding its protein product. Alternatively, some miRNA-mRNA interactions may 
recruit decay factors that mediate template destabilization or degradation.89-90 Most 
miRNAs are synthesized from a canonical pathway (Fig. 10).91 Primary miRNA 
transcripts (pri-miRNAs) are transcribed from introns, non-coding exons, or intergenic 
regions and processed by RNase III Drosha into smaller, 70-100 nucleotide pre-miRNAs. 
Exportins transfer pre-miRNAs from the nucleus to cytoplasmic compartment, where 
there are cleaved by another RNase III Dicer into double-stranded miRNA:miRNA 
duplexes. These intermediate duplexes are then processed by RNA-induced silencing 
complex (RISC) to form the mature miRNA strand.  
miRNAs are important regulators of various cellular processes, including 
differentiation and proliferation of diverse tissue types.92 Interestingly, they may be 
secreted within microvesicles, exosomes, high-density lipoproteins, or RNA-binding 
proteins in blood and transported to other tissues.90-92 miRNAs represent an emerging 
class of therapeutics currently tested in clinical trials.89 Although not yet developed, 
miRNAs that selectively promote WAT browning, increase EE, and/or enhance fuel 
substrate metabolism are of significant interest for anti-obesity treatment.  
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Within the past few years, transcriptomic screening has identified numerous 
miRNAs that regulate brown/beige adipogenesis and function in primary adipocyte 
culture and genetic mouse models (Table 2).92 However, a far fewer selection have 
validated target gene interactions and shown to demonstrate actual biological effects thus 
far, especially in the context of human models. A subset of such miRNAs, including 
miR-26a, Let-7i-5p, and miR-32 will be emphasized here. 
 
Figure 10 – Biogenesis of miRNAs. Abbreviations: DGCR8 (DiGeorge critical 
region 8), a double-cysteine-ligated heme protein; Drosha, a RNase III; Dicer, a 
RNase III; TRBP (trans-activating response RNA-binding protein); RISC (RNA-
induced silencing complex). Figure adapted from Arias et al. (2016).91 
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Table 2 – MicroRNAs involved in browning, corresponding to validated beige target 
genes in mouse and human. References refer to those cited in Arias et al. (2016).91 
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Karbiener et al.93 identified members of the miRNA-26 family as key regulators 
of early adipogenesis and lipid accumulation in human multipotent adipose-derived stem 
(hMADS) cells, which can be directed towards white or beige lineages. miR-26a-
transfected hMADS cells revealed strong increases in brown/beige marker expression 
(e.g. UCP1, PPARγ, FABP3, ADRB1, and PRDM16), UCP1 protein levels, mitochondrial 
biogenesis, and oxygen consumption compared to control cells. Immunofluorescence 
microscopy analysis of single cells resulted in ~ 50% UCP1+ adipocytes in the transfected 
pool.   
Complementing in vitro data, miR-26a was preferentially enriched in mouse BAT 
and inguinal WAT during cold exposure; however, genetic models to explore this 
observation further were not pursued. Mechanistically, in silico analysis and luciferase 
reporter assays revealed that miR-26a directly targets ADAM metallopeptidase 17 
(ADAM17) gene expression, a protein previously described to help regulate non-
shivering thermogenesis.94 How suppression of ADAM17 expression increases UCP1 
expression in hMADS cells and promotes browning in vivo will be of high interest.  
Giroud et al.95 used beige-differentiated hMADS cells (induction using 
rosiglitazone, a PPARγ agonist) to identify Let-7i-5p as a miRNA that represses beige 
adipocyte function in mice and humans. Previously, members of the Let-7 miRNA family 
had been reported to modulate UCP1 levels in bone marrow derived adipocytes.96 
Furthermore, studies implicate Let-7 miRNAs in the regulation of glucose metabolism, 
control of insulin sensitivity, and adipocyte differentiation.96-97  
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Let-7i-5p levels were lower in brown/beige adipocytes isolated from cold-
exposed human BAT biopsies. Let-7i-5p overexpression in beige-differentiated hMADS 
cells led to a significant decrease in UCP1 mRNA and protein levels and reduction in 
basal oxygen consumption rate.93 In mice, low levels of Let-7i-5p were similarly found in 
beige inguinal WAT. Overexpression directed in the inguinal fat pad simultaneously 
treated with CL 316,243 limited beige cell recruitment, blunting the expression of key 
beige marker genes like Ucp1, Prdm16, and Cidea. These results were confirmed by 
histological analysis and electron microscopy of mitochondrial morphology. Taken 
together, Giroud et al. showed that Let-7i-5p is a negative regulator of beige 
differentiation and function, but did not provide mechanistic insights. It will be 
interesting to see in future studies if Let-7i-5p inhibition can significantly promote WAT 
browning in vivo.  
Lastly, Ng et al.98 have reported miR-32 as a factor that not only drives BAT 
thermogenesis in mice, but also acts in trans to promote WAT browning via fibroblast 
growth factor 21 (FGF21). miR-32 represses Tob1, which encodes an inhibitor of the 
p38/MAPK pathway, to upregulate thermogenic markers like PGC1a and UCP1 in BAT. 
Mice treated with miR-32 allele-specific oligonucleotide (ASO) exhibited impaired cold 
tolerance, reduced EE, and decreased beige cell emergence in inguinal WAT during 7-
day cold challenge. However, direct injection of miR-32-ASO in inguinal adipose depots 
under cold stress did not lead to a significant reduction in browning. Instead, the miR-32-
Tob1-p38/MAPK pathway indirectly stimulated beige adipogenesis by promoting BAT-
derived FGF21 secretion.  
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FGF21, normally produced by the liver, has been well described as an important 
signaling molecule that regulates glucose homeostasis, insulin sensitivity, and brown 
adipocyte activation.99-101 During cold stress, hepatic FGF21 expression is significantly 
reduced, while miR-32-Tob1-p38/MAPK pathway activation induces a secretory switch 
to BAT-derived FGF21 production. Unlike other miRNAs that act in cis to regulate 
brown/beige adipocytes, miR-32 is one of the few microRNAs comprehensively shown 
to promote browning in vivo, although not capable of driving beige adipogenesis 
autonomously. Thus, miR-32 mimetics or Tob1 inhibitors may constitute therapeutic 
reagents against obesity and metabolic syndrome.  
MicroRNAs like mIR-26a, Let-7i-5p, and miR-32 can act on a large set of mRNA 
targets to influence brown/beige differentiation, energy expenditure, and expression 
thermogenic molecular machinery. These powerful genetic determinants constitute 
another complex layer of brown/beige fat regulation;102 however, the whole picture of 
this developmental network is incomplete. For other diseases, pharmacological agents 
aimed to restore or antagonize miRNA function have already begun clinical testing.103 
For example, an anti-mIR-22 ASO inhibitor (Miravirsen) shown to effectively reduce 
hepatitis C viral load has already entered Phase 2a clinical trial,104 while a mIR-34 mimic 
(MRX34) designed to suppress liver cancer is in Phase 1.105 Much research is needed to 
explore the molecular action of miRNAs in adipose tissue and whether miRNA 
therapeutics can be delivered to the proper WAT depot in a time and dose-controlled 
manner in humans. Nevertheless, it is inconceivable that miRNAs represent a promising 
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pharmacological avenue that may be used to combat metabolic diseases like obesity and 
diabetes.  
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TRANSPLANTATION OF BEIGE ADIPOCYTES 
 
In addition to pharmaceutical or genetic interventions to induce beige 
differentiation and activation in vivo, transplantation of beige adipocytes is a therapeutic 
strategy that has recently gained significant interest. Transplantation has been a 
traditional research tool in the field of endocrinology, which was previously used to 
uncover the secretory role of WAT, which releases adipokines like adiponectin and 
leptin.106 Unlike various browning agents that offer little control over the location and 
extent of their action in WAT depots and run the risk of ectopic effects, BAT 
transplantation theoretically provide a more precise spatio-temporal control of beige 
adipocyte number and activity.  
Several groups have reported that BAT transplantation restores glucose tolerance, 
reduces weight gain, and increases insulin sensitivity in high-fat-diet induced obese 
mice.107-109 Stanford et al.107 found that BAT transplantation could even reverse high-fat-
diet induced obesity and insulin resistance by 12-weeks post procedure. It was unclear 
whether transplantation targeted WAT and BAT of recipients and/or endogenous BAT 
and muscle. Slight phenotypic discrepancies in transplantation studies appeared to 
depend on site of transplantation and age of donors/recipients.107-109  
Liu et al.109 reported that subcutaneous transplantation of BAT (~0.2 g) from 
healthy lean mice reversed obesity in leptin-deficient (Ob/Ob) obese mice, accompanied 
by an improvement in various metabolic parameters. Surprisingly, hepatic steatosis was 
alleviated, likely due to increased expression of PGC1a, which helps regulates hepatic 
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fatty acid metabolism. Consequently, circulating triacylglycerol, cholesterol, and low-
density lipoproteins were significantly decreased. Although activated BAT consumes 
large amounts of FFA and glucose, there were no changes in FA-related gene expression 
within transplanted BAT. However, increased expression of these FA-related genes and 
b3-AR were observed in endogenous BAT, suggesting a concomitant increase in pre-
existing BAT activity, but not exogenous transplanted BAT per se. It is possible that the 
metabolic benefits of transplanted BAT are due to its ability to elicit diverse signals that 
positively influence metabolism, targeting the liver, endogenous BAT, and other organ 
systems.  
Although transplantation studies in rodents have begun to emerge, human-to-
human BAT transplantation has yet to be done and is perhaps not likely due to low 
quantities of BAT in adults, on top of the risk of host-versus-graft rejection.110-111 To 
successfully translate this approach to humans, beige adipocytes with thermogenic 
capacity (e.g. UCP1+) must be generated and incorporated into a functionally-active, non-
immunogenic adipose tissue. Secondly, these transplanted cells should also be capable of 
pharmacological activation in a controlled manner. Notably, it has been shown that 
murine beige adipocytes possess an innate capacity to sense changes in temperature and 
respond by increasing Ucp1 expression for thermogenic activation.41 This is unlike 
classical brown adipocytes, which directly depend on sympathetic innervation and 
immune factors to initiate and maintain thermogenesis.32 This distinction supports the 
feasibility of beige adipose transplants, which may not require host neuronal signals to 
induce the thermogenic program.   
	 	 	
  36 
At this time, the main source of beige adipocytes are from multipotent stem cells 
(MSCs), which are then induced for beige differentiation.112-113 In the future, 
preadipocytes may theoretically be isolated from human WAT and sorted by known 
markers for possible transdifferentiation.114 MSCs can be isolated/purified from WAT 
depots, differentiated ex vivo, then implanted back into the derived depot.113 They are 
most commonly derived from the stromal vascular fraction (SVF), which is rich in 
preadipocytes, mesenchymal stem cells, endothelial progenitor cells, and numerous 
immune cell types (e.g. B cells, T cells, adipose macrophages).113 Various components of 
the vascular and immune systems, including cytokines and growth factors, compose a 
microenvironment conducive for browning and beige adipocyte function.35-37,110-111  
Transplants must be well vascularized to enable proper access to metabolic 
substrates, oxygen, and circulating activating/browning signals, all the while supported 
by a functional immune system and dynamic extracellular matrix (ECM).113 
Consequently, as beige biology continues to be elucidated, it is probable that direct 
transplantation of beige adipocytes alone may not yield successful adipose integration, 
but rather, may require multiple SVF-derived components or cell populations to solidify a 
functional organoid.115 Indeed, cell adhesion and matrix interactions derived from ECM 
components have been shown to exert significant control over MSC differentiation.112-
113,116  
Tharp et al.116 considered these important conditions by engineering a 3D 
hydrogel encompassing adipose-derived MSCs (ADMSCs) and ECM components 
optimized to establish functional brown/beige fat-like depots in vivo (Figure 11). The 
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hydrogel, termed beige adipose tissue matrix-assisted cellular transplant (BAT-MACT), 
was composed of a hyaluronic acid (HyA) macromeric core, along with adhesion ligands, 
crosslinkers, and other components. This system was designed to evenly distribute and 
stabilize ADMSCs through biophysical interactions, which greatly enhanced their 
differentiation into UCP1+ beige adipocytes in vitro. BAT-MACT augmented UCP1 
mRNA expression >10-fold higher than that of comparable cultured MACTs.113 Direct 
injection of BAT-MACT into subcutaneous WAT pads of recipient mice improved their 
metabolic profiles over a 4-week period in many ways, including: improved cold 
tolerance, reduced weight gain, increase resting EE, and enhanced glucose tolerance. 
Impressively, UCP1 protein levels reached ~30% of that in endogenous BAT for each 
recipient. 
 In summary, hydrogel-based therapies like BAT-MACT are minimally invasive 
options that can complement pharmacological and cell-based approaches.117 Adipose-
derived MSCs are easily extractable and readily available118 and may be more efficiently 
purified by sorting for UCP1-enriching markers (e.g. CD24, CD29, and CD137).116 The 
viscoelastic nature of the BAT-MACT scaffold may permit the inclusion of additional 
growth factors, small molecules, and other materials that may further promote beige 
adipogenesis and activation in vivo. Perhaps also, cell-free matrix implants may contain 
biochemical signals to sufficiently recruit and direct endogenous host MSCs towards a 
beige phenotype.   
 
 
	 	 	
  38 
 
 
 
Using a different approach, Guénantin et al.119 reported a novel protocol for the 
differentiation of human induced pluripotent stem cells (hiPSCs) into beige adipocytes 
involving a three-step mesodermal induction, adipogenic stimulation, and adipocyte 
maturation procedure (Fig. 12). Their method differed from that of Tharp et al. by 
utilizing separate hormonal differentiation steps, rather than relying on a 3D hydrogel. 
Their work complemented and improved on previous studies describing the generation of 
iPSC-derived brown adipocytes.120 In hiPSC-derived cell lines, numerous beige selective 
markers (e.g. CITED1, TMEM26, HOXC9) were upregulated, while the brown-selective 
markers MYF5 and ZIC1 were not detected during differentiation, suggesting that these 
Figure 11 – Beige adipose tissue-matrix assisted cellular transplant (BAT-MACT). There 
are 6 stages for expanding beige adipose tissue in this system: (i) Isolation of white 
adipose tissue (WAT) from patient. (ii) Purification of stromal vascular fraction (SVF) 
from the explanted WAT. (iii) In vitro differentiation of SVF-derived preadipocytes 
toward a beige phenotype. (iv) Suspension of mature beige adipocytes into optimized 
hydrogel for implantation. (v) Post implantation, the hydrogel is biocompatible and 
degradable, allowing proper integration with recipient’s vascular, immune, and nervous 
systems. (vi) The established beige adipose tissue functions as a metabolically active 
organ (BAT-MACT). In theory, if the beige implant is sufficiently activated, increases in 
energy expenditure and metabolic rate will occur, eventually leading to weight loss. 
Figure adapted from Tharp et al. (2015).113  
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cells were not derived from a BAT lineage. Subcutaneous injection of hiPSC-derived 
adipocytes in mice resulted in the formation of fully differentiated and vascularized 
adipose tissue in newly formed fat pads, as shown by beige and white adipocyte marker 
staining. b-adrenergic stimulation in vivo increased FDG-uptake in neoformed pads while 
upregulating thermogenic genes, including PGC1A, PRDM16, PPARA, and DIO2. 
Additionally, lipid droplet diameter was reduced and mitochondrial content increased, 
consistent with beige adipocyte morphology. Altogether, the scalability and short 
timeframe (20 days) of this protocol may provide an unlimited source of cells for beige 
adipose modeling and therapeutic screening.   
 
 
 
 
 
 
Figure 12 – Differentiation of hiPSCs into beige adipocytes. RT-qPCR analysis of 
markers expression was used for each induction step. For the first step (D0), BMP4 and 
activin A induce mesodermal development and loss of pluripotency. Second (D4), 
mesodermal precursors are subjected to an adipogenic cocktail lacking thizolidinedione 
(to bypass overexpression of key adipogenic pathway), increasing expression of adipose 
progenitor markers (e.g. PDGFRA, CD44, CD29) similar to those observed in human 
primary adipose stem cells. Third (D10), adipose progenitors are exposed to insulin to 
culture mature, functional adipocytes that are insulin responsive (i.e. IR and AKT 
activation), validated by classical markers (e.g. PPARG, CEBPA). Figure adapted from 
Guénantin et al. (2017).119  
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DISCUSSION 
 
Our understanding of brown and beige adipose tissue formation and physiology 
has grown immensely in the past decade. Until recently, brown fat was thought to only 
exist in human infants and small mammals, which defends against hypothermia by 
adaptive thermogenesis.8 But, in 2009, several groups “rediscovered” human brown/beige 
fat in adults, employing the use of FDG-PET/CT imaging.19-20 Energy expenditure 
estimates of maximal cold-induced BAT thermogenesis lie between 25 and 400 kcal/day 
in lean healthy volunteers,43,121-122 but it has been difficult to achieve high, prolonged 
activation in obese people through cold exposure protocols.123 However, if beige fat can 
be induced in subcutaneous adipose depots of humans, it may be possible to significantly 
increase thermogenesis and EE.  
Early cold acclimation studies in rodents and humans first suggested the attractive 
recruitability of beige adipocytes, opening the door for pharmacological interventions 
targeting this cell type for treatment of obesity. Unfortunately, although cold exposure 
and/or b-adrenergic stimulation are extensively used in WAT browning experimentation 
in mice, these therapeutic approaches are difficult to implement for clinical applications. 
A number of alternative approaches to browning have been introduced here, including 
various lifestyle modifications and novel pharmacologic avenues such as including 
miRNAs and beige fat transplantation. Continued basic research and prospective 
longitudinal studies are urgently needed to evaluate their therapeutic potential.   
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Since the study of WAT browning is so novel, the physiological roles of beige fat 
in metabolic homeostasis are not yet fully determined, but are beginning to be uncovered. 
Two recent discoveries include (i) a futile creatine cycle utilized by beige adipocytes to 
produce heat124-125 and (ii) emerging evidence of a brown/beige adipose tissue 
secretome.127 These important facets of beige fat biology are beginning to restructure our 
criteria for beige adipocyte identification, characterization, and function. As a result, it is 
important to develop more accurate human BAT detection methods.    
 
Futile creatine cycling – an UCP1-independent mechanism 
UCP1 has long been considered essential for beige adipocyte thermogenesis, as 
observed in classical brown adipocytes, but recent reports124-125 describe an alternative 
futile creatine phosphorylation/dephosphorylation cycle that can be utilized for heat 
production (Figure 13). Indeed, UCP1 deficient mice have been found to still be able to 
adapt to gradual cold acclimation by non-shivering thermogenesis.126 This observation 
had previously confused researchers and suggested the possibility of alternative 
thermogenic mechanisms. 
Briefly, ATP formed by ATP synthase is exported from the matrix in exchange 
for ADP. ATP is used by creatine kinase (CK) to phosphorylate creatine (Cr) to produce 
phosphocreatine (PCr) and ADP (reimported). A phosphatase, likely Phospho1, then 
completes the futile cycle by dephosphorylating PCr. As a result, cyclic 
phosphorylation/dephosphorylation of Cr at the expense of ATP generates heat.  
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Using quantitative mitochondrial proteomics, Kazak et al.125 found that in murine 
beige fat, cold exposure stimulated CK (genes Ckmt1/2) activity and expression of other 
genes related to creatine metabolism. To determine the contribution of creatine cycling in 
Figure 13 – Creatine cycle is present in both UCP1-positive and UCP1-negative beige 
adiopcytes. UCP1-positive cells utilize both UCP1- and creatine cycle-mediated 
thermogenesis for heat production in a non-redundant manner. However, the UCP1 
mechanism predominates for energy expenditure. UCP1-negative cells are a newly 
identified cell type within beige fat that exhibits similar morphological character as 
UCP1-positive cells. However, they solely utilize creatine cycling for thermogenesis. 
Interestingly, UCP1-negative cells have the same UCP1 mRNA transcript levels as 
UCP1-positive cells, but lack protein expression, suggesting a not-yet elucidated post-
transcriptional regulation. Figure taken from Bertholet et al. (2017).124  
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brown/beige adipose to whole body EE, mice were co-treated with b3-adrenergic agonist 
CL 316,243 (CL) to stimulate thermogenesis, along with either oral b-guanidinopropionic 
acid (b-GPA), a creatine analog known to reduce creatine levels in tissues by ~50%, or 
vehicle control. As expected, CL increased metabolic rate by 54%; however, b-GPA 
administration strikingly decreased the CL-induced increase in whole body oxygen 
consumption by ~40% compared to vehicle treatment. Tissue analysis showed that this 
attenuating effect was mainly mediated by b-GPA action on beige inguinal WAT and to a 
lesser extent, classical BAT. Notably, creatine supplementation to b-GPA + CL-treated 
mice completely rescued this effect.  
In 2017, Bertholet et al.124 identified beige UCP1-less adipocytes co-existing with 
UCP1-expressing cells predominantly in epididymal WAT of mice. They patch clamped 
single mitoblasts isolated from beige fat depots to quantify thermogenic H+ leak (IH), 
which occurs via UCP1. In inguinal WAT, functional UCP1 was detected in almost all 
beige adipocytes upon b-adrenergic stimulation. Unexpectedly, only ~15% of epididymal 
beige adipocytes had IH (UCP1-positive) and undetectable IH in the other ~85% (UCP1-
negative). UCP1-negative cells were similar to UCP1-positive cells in many ways, 
including multilocularity, robust mitochondrial biogenesis, and creatine cycle activity. 
But, the UCP1-negative class relied solely on creatine-driven respiration for 
thermogenesis, which was non-redundant and varied from UCP1-dependent regulatory 
mechanisms. Notably, UCP1 expression in epididymal and inguinal beige fat was an all-
or-nothing affair: either the protein was expressed at high levels or not at all. 
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From all these data, it follows that UCP1 is not mandatory for thermogenesis and 
is thus not a sufficient marker for beige adipocytes. The existence of UCP1-negative 
thermogenic cells has been previously overlooked in numerous studies and presents new 
challenges for the identification of beige adipocytes in mouse and human. Currently, the 
question of why b-adrenergic and cold stimulation promotes the emergence of UCP1-
negative beige adipocytes in a tissue-specific manner is still unanswered. A better 
understanding of thermogenic pathways utilized by UCP1-negative beige adipocytes, like 
the creatine cycle, can help fully delineate their contribution to adipose energy 
expenditure and uncover new targets for obesity treatment.  
 
New methods for brown/beige adipocyte detection and identification 
The most common method for human BAT detection is 18F-FDG-PET/CT, which 
measures a “tumor-like” glucose uptake in body tissues. However, it is an inaccurate 
technique for measuring activated total BAT mass for many reasons. Firstly, it does not 
take in account the uptake of free fatty acids, a major fuel source used in UCP1-mediated 
heat generation.123 The use of other tracers like 11C and 15O have been explored to a more 
limited extent.123,128 Secondly, recent data indicate that PET-CT preferentially localizes in 
dense regions of BAT, and can yield false positives in PET-CT negative fat biopsies.22 
Thirdly, it does not provide sufficient sensitivity and resolution to detect beige adipocytes 
(UCP1-positive/negative) in adipose depots outside of the supraclavicular region, like 
visceral and subcutaneous fat.123 Moreover, the risk of repeated exposure to ionizing 
radiation makes its use limited for repetitive studies.  
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MRI scans have been used as an alternative to FDG-PET/CT, which minimizes 
risk of high radiation exposure (Figure 14).129 Relaxometry-based (T1, T2) and chemical-
shift-based approaches can allow more accurate visualization of regional and whole-body 
fat distribution.129 One of the key traits of brown/beige adipose tissue is its dense 
perfusion with capillaries, which assists the transport of fuel substrates and dispersion of 
produced heat.6,8,9,11 MR techniques can exploit this characteristic by differentiating fat 
and water proton signals. Nevertheless, MRI use for human subjects may not be realistic 
due to its cost and relative inaccessibility in some clinical and laboratory settings. Other 
imaging technologies like near-infrared (NIR) fluorescence imaging coupled to BAT-
targeted peptide probes have recently been performed in rodents.130  
Besides imaging modalities, researchers can monitor BAT activity using BAT 
biomarkers.130 Biomarkers are circulating molecules found in body fluids that can be 
detected and quantified, which indicate a certain biological state like BAT thermogenesis 
or WAT browning.130 Currently, there are very few biomarkers that can be conveniently 
assessed by blood analyses, but circulating miRNAs show diagnostic potential. 
Dysregulated miRNA signatures detected in tissue, blood, and other fluids are established 
biomarkers and prognostic values for various cancers.131  
Recent studies suggest that BAT has metabolic roles beyond thermogenesis by 
acting as a secretory tissue.127 Thomou et al.132 showed that mice with adipose-specific 
knockout of the miRNA-processing enzyme Dicer (ADicerKO) exhibit a substantial 
decrease in circulating exosomal miRNAs. Transplantation of unmodified brown adipose 
tissue into ADicerKO mice restored the levels of numerous miRNAs associated with 
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improved glucose tolerance and reduction in hepatic FGF21. Thus, exosomal miRNA 
species (e.g. miRNA-92a)90 may serve as BAT-specific biomarkers, which can be 
exported to other tissues for inter-organ regulation like other adipokines. Further research 
on the brown/beige fat secretome may uncover new molecular targets and biomarkers 
(Figure 15).130-132   
 
 
 
Figure 4 – Fat-signal fraction images from chemical-shift encoded water-fat MRI of 
BAT in (A) infants and (B) adolescents. The 0-100 scale represents fat-signal fraction in 
percent values. Arrow points to supraclavicular BAT depots, which have a lower fat-
signal fraction (green-yellow) than the TG-rich subcutaneous WAT (red shade, dotted 
arrow).  In the lower-right two infant images in (A), the thin interscapular BAT depot is 
clearly visible (dashed arrow, green patch) underneath the WAT layer. In (B), the lung 
space has been cropped. As expected, fat-signal fractions of BAT are significantly higher 
in adolescents than in infants. Figure adapted from Hu & Kan (2013).129  
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The future of beige adipocytes 
In the past decade, increased interest in research pertaining to the beige adipocyte 
has enriched our understanding about its developmental origin, differentiation, and 
activation in rodents and humans. However, several key issues continue to be addressed: 
What other physiological roles beige fat have besides thermogenesis? As 
discussed, exercise may induce browning and thermogenesis, a condition that seems 
Figure 15 – Secreted factors by brown fat. Neuregulin 4 (Nrg4) is an endocrine 
factor that is enriched in brown fat. Nrg4 binds to ErbB receptors in the liver and 
attenuates hepatic lipogenesis. FGF21 is induced in brown fat by cold exposure and 
exerts effects on WAT browning, SNS innervation, and BAT thermogenesis. 
Additional secreted factors include bone morphogenetic protein (BMP), vascular 
endothelial growth factor A/B (VEGFA/B), IL-6, adiponectin, and metabolites 
released upon thermogenic activation, such as FFA and lactate. Figure taken from 
Wang et al. (2015).127  
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energetically counterproductive. Activated brown/beige adipose tissue enhances glucose 
and FFA substrates, which may be helpful for the management of type 2 diabetes and 
dyslipidemia. Furthermore, emerging research on the BAT secretome will provide insight 
into how BAT-derived circulating factors coordinate inter-organ regulation for systemic 
metabolic homeostasis.  
Can we successfully translate rodent mechanistic data to humans and use it to 
unlock the thermogenic potential of human BAT? Can beige adipocytes be recruited in 
multiple white adipose depots, besides the supraclavicular region? Perhaps brown/beige 
fat is a thermogenic vestigial tissue that is physiologically relevant in infants and small 
rodents.18 A few approaches among numerous classes of browning therapeutics are 
addressed here, but many of their underlying mechanisms are unfortunately not fully 
understood. Lifestyle interventions addressed here, such as diet and exercise, may 
indirectly induce browning as consequence of complex physiological events like immune 
system activation.   
Finally, does browning of WAT have adverse effects? Much research have 
focused on unlocking the thermogenic potential of brown/beige adipose tissue in humans, 
but a dearth of studies on its potential adverse effect.133 Three new studies134-136 have 
discovered a drastic phenotypic switch from WAT to BAT in patients with 
hypermetabolic conditions, like cancer, massive trauma, and burns. Logically, it would 
seem counterproductive to activate heat production and nutrient utilization in patients 
with an already highly catabolic state. WAT browning was shown to increase incidence 
of cachexia (muscle/adipose wasting), atherosclerosis, and hepatic steatosis due to 
	 	 	
  49 
increased lipolysis and EE. As intriguing browning agents and therapeutics continue to be 
developed, researchers should strive to minimize side effects that are associated with 
metabolic dysfunction. Clinicians too should consider their patients’ preconditions (e.g. 
cancer) before directing ‘browning’ regimens in the future. The expanding diversity of 
research in this field not only highlight the largely unexplored biology of beige 
adipocytes, but also the urgent need to find new treatments for obesity.  
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